RNU6-504P

Across TCGA pan-cancer cohorts, RNU6-504P RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated RNU6-504P data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher RNU6-504P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-504P expression acts as an unfavorable survival marker, although some lineages such as OV and LIHC show a favorable association.

CHOL, OV, and UCEC are the cancer types where RNU6-504P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Tertile	II,III,IV	0.066	0.761	<.001	117	view →
OV	DFS	Tertile	II,III,IV	0.452	0.362	.017	36	view →
UCEC	DFS	Tertile	All	0.759	0.900	.002	36	view →
MESO	DFS	Tertile	II,III,IV	0.192	0.521	.024	27	view →
LIHC	DFS	Tertile	III,IV	0.761	0.160	.030	24	view →
BLCA	OS	Tertile	All	0.231	0.604	.023	18	view →
STAD	OS	Quartile	All	0.775	0.619	.009	16	view →
THYM	OS	Tertile	II,III,IV	0.395	0.863	.014	12	view →
TGCT	DFS	Tertile	All	0.677	0.853	.025	12	view →
PAAD	OS	Tertile	All	0.217	0.528	.026	9	view →
COAD	DFS	Tertile	IV	0.028	0.496	<.001	9	view →
KIRP	OS	Tertile	All	0.869	0.953	.034	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

RNU6-504P–CHOL (OS)

Open the CHOL breakdown →